Novel HSP90 Inhibitor NVP-AUY922 Enhances the Anti-tumor Effect of Temsirolimus Against Oral Squamous Cell Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|3|289-299

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.3, 2013-03, pp. : 289-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Taxol: Efficacy Against Oral Squamous Cell Carcinoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 509-521

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Selenosemicarbazone Metal Complexes Exert Anti-tumor Effect via Alternative, Caspase-independent Necroptotic Cell Death

By  

Medicinal Chemistry, Vol. 10, Iss. 8, 2014-12 ,pp. : 759-771

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic and Preventive Effects of an Epidermal Growth Factor Receptor Inhibitor on Oral Squamous Cell Carcinoma

By Ge H   Liu H   Fu Z   Sun Z  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 455-466

Field House Publishing

Access to resources Recommend Favorite

Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents

By  

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1131-1138

Bentham Science Publishers

Access to resources Recommend Favorite

Antiproliferative Effect of HSP90 Inhibitor Y306zh Against Pancreatic Cancer is Mediated by Interruption of AKT and MAPK Signaling Pathways

By  

Current Cancer Drug Targets, Vol. 14, Iss. 7, 2014-09 ,pp. : 671-683

Bentham Science Publishers

Access to resources Recommend Favorite